Clinical and Translational Research
Copyright ©The Author(s) 2023.
World J Hepatol. Dec 27, 2023; 15(12): 1294-1306
Published online Dec 27, 2023. doi: 10.4254/wjh.v15.i12.1294
Table 2 Transition in etiological proportions over 20 years, n (%)
Etiology
2001-2005, n = 2870
2006-2010,
n = 5123
2011-2015, n = 10538
2016-2020, n = 14612
P value1
P value2
Viral hepatitis2444 (85.2)4046 (79.0)8385 (79.6)11418 (78.1)< 0.0010.780
    HBV2366 (82.4)3852 (75.2)7788 (73.9)10835 (74.2)< 0.0010.747
    HCV66 (2.3)159 (3.1)484 (4.6)474 (3.2)0.9510.912
    HBV + HCV12 (0.4)35 (0.7)113 (1.1)109 (0.7)0.6850.932
Alcohol155 (5.4)304 (5.9)753 (7.1)1155 (7.9)< 0.0010.869
Autoimmune hepatitis12 (0.4)41 (0.8)87 (0.8)170 (1.2)< 0.0010.875
Cholestatic29 (1.0)92 (1.8)154 (1.5)266 (1.8)0.0050.925
Genetic or Metabolic21 (0.7)62 (1.2)105 (1.0)191 (1.3)0.0190.923
Mixed etiology102 (3.6)374 (7.3)864 (8.2)1188 (8.1)< 0.0010.771
Cryptogenic74 (2.6)153 (3.0)70 (0.7)36 (0.2)< 0.0010.746